What drives choice of artificial pancreas? survey reveals patient priorities
NCT ID NCT07177404
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study surveyed 166 adults with type 1 diabetes to understand what factors influence their choice of hybrid closed-loop (artificial pancreas) systems. Participants included those already using, waiting to start, or considering such technology. The goal was to learn what matters most to patients when selecting a system that automatically adjusts insulin delivery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospitals of Derby and Burton
Derby, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smart pen take the guesswork out of insulin dosing?
- AI takes the wheel: could a smart algorithm optimize insulin pumps from home?
- Antioxidant-rich diets may fight inflammation in type 2 diabetes — a study investigates
- Can a common diabetes pill make insulin therapy safer and more effective for type 1 diabetes?
- Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
- Could vinegar and fasting fix prediabetes cholesterol?